Off-Label Prescription of Anticancer Drugs in Italy: What Responsibilities?

Gota V. , Patial P. : Off-label use of anti-cancer drugs in India: to be or not to be! J Cancer Res Ther, 7: 35–39, 2011.

Casali PG ; Executive Committee of ESMO: The off-label use of drugs in oncology: a position paper by the European Society for Medical Oncology (ESMO). Ann Oncol, 18: 1923–1925, 2007.

Poole S.G. , Dooley M.J. : Off-label prescribing in oncology. Support Care Cancer, 12: 302–305, 2004.

Roila F. , Ballatori E. , Labianca R. , De Braud F. , Borgonovo K. , Martelli O. , Gallo C. , Tinazzi A. , Perrone F. ; Italian Medical Oncology Association (AIOM): Off-label prescription of anti-neoplastic drugs: an Italian prospective, observational, multicenter survey. Tumori, 95: 647–651, 2009.

Leveque D. : Off-label prescriptions: patient safety first. Lancet Oncol, 12: 825, 2011.

Rescigno P. , Imbevaro S. , Jirillo A. : The economic crisis and cancer chemotherapy: the role of the oncologist. Tumori, 98: 532–533, 2012.